These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19439020)

  • 41. Vaccine decisions loom for new flu strain.
    Butler D
    Nature; 2009 May; 459(7244):144-5. PubMed ID: 19444174
    [No Abstract]   [Full Text] [Related]  

  • 42. How can we solve the enigma of influenza vaccine-induced protection?
    Neuzil KM
    J Infect Dis; 2015 May; 211(10):1517-8. PubMed ID: 25416811
    [No Abstract]   [Full Text] [Related]  

  • 43. Swine flu vaccines: reaching the finish line.
    Davies J
    Cell; 2009 Oct; 139(3):449-51. PubMed ID: 19879829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventing influenza coinfection among HIV-infected persons: a complex picture coming into focus.
    Reyes-Teran G; Butera ST
    AIDS; 2010 Sep; 24(14):2283-5. PubMed ID: 20651584
    [No Abstract]   [Full Text] [Related]  

  • 45. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)].
    Haas W
    MMW Fortschr Med; 2009 Aug; 151(34-35):12. PubMed ID: 19771780
    [No Abstract]   [Full Text] [Related]  

  • 47. Better influenza vaccines for older people: what will it take?
    McElhaney JE; Dutz JP
    J Infect Dis; 2008 Sep; 198(5):632-4. PubMed ID: 18652548
    [No Abstract]   [Full Text] [Related]  

  • 48. Swine flu outbreak. China first to vaccinate against novel H1N1 virus.
    Stone R
    Science; 2009 Sep; 325(5947):1482-3. PubMed ID: 19762610
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
    Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza vaccine in the red zone defense: a game-day player.
    Peters TR; Poehling KA
    J Infect Dis; 2014 Sep; 210(5):671-3. PubMed ID: 24676206
    [No Abstract]   [Full Text] [Related]  

  • 52. US puts flu vaccines on trial. Interview by Declan Butler.
    Fauci A
    Nature; 2009 Jul; 460(7255):562. PubMed ID: 19641566
    [No Abstract]   [Full Text] [Related]  

  • 53. Thinking about broadly cross-reactive vaccines.
    Doherty PC; Turner SJ
    Clin Pharmacol Ther; 2009 Jun; 85(6):665-8. PubMed ID: 19404249
    [No Abstract]   [Full Text] [Related]  

  • 54. [H1N1 vaccination. A state imposed chaos].
    Walbert H
    MMW Fortschr Med; 2009 Oct; 151(42):12. PubMed ID: 19938772
    [No Abstract]   [Full Text] [Related]  

  • 55. Influenza vaccination in Europe--still a long way to go.
    Ruef C
    Infection; 2007 Oct; 35(5):299. PubMed ID: 17885727
    [No Abstract]   [Full Text] [Related]  

  • 56. [The elderly profit from adjuvanated influenza vaccines].
    MMW Fortschr Med; 2006 Nov; 148(46):54-5. PubMed ID: 17615792
    [No Abstract]   [Full Text] [Related]  

  • 57. Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
    Abbasi J
    JAMA; 2021 Jan; 325(2):121. PubMed ID: 33433563
    [No Abstract]   [Full Text] [Related]  

  • 58. Novel attack on influenza.
    Br Med J; 1973 Feb; 1(5850):373-4. PubMed ID: 4691058
    [No Abstract]   [Full Text] [Related]  

  • 59. Valuable data surrounding the priming and boosting abilities of various vaccine technologies.
    Toback S; Ambrose C
    Vaccine; 2009 Jan; 27(3):349. PubMed ID: 19027811
    [No Abstract]   [Full Text] [Related]  

  • 60. Valuing influenza vaccine: medical, economic, and social benefits.
    Poland GA
    Clin Infect Dis; 2009 Feb; 48(3):299-301. PubMed ID: 19115975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.